References,Sample size,Interventions,Main race,Female (%),Mean HAMA,Mean age (Year),Attrition rate (%),Sponsor,Follow-up time (weeks),Diagnosis criteria
"Kasper et al., 2014",539,silexan: 160 mg/day,Caucasian,73.6,26.0,47.1,18.0,Dr. Willmar Schwabe GmbH & Co. KG,10,dsm-iv-tr
"Kasper et al., 2014",539,silexan: 80 mg/day,Caucasian,70.4,25.8,45.7,11.9,Dr. Willmar Schwabe GmbH & Co. KG,10,dsm-iv-tr
"Kasper et al., 2014",539,paroxetine: 20 mg/day,Caucasian,77.3,25.8,45.8,21.2,Dr. Willmar Schwabe GmbH & Co. KG,10,dsm-iv-tr
"Kasper et al., 2014",539,placebo,Caucasian,73.3,25.1,44.6,13.2,Dr. Willmar Schwabe GmbH & Co. KG,10,dsm-iv-tr
